Form 4: Omada Health Director Anne Beal Receives Significant RSU Grant

Omada Health, Inc. Director Anne Beal was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which will fully vest on the first anniversary of the grant date.

Summary

• Director Anne Beal of Omada Health, Inc. was granted 9,736 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 5, 2025, and was reported on June 9, 2025.
• These RSUs were acquired at a price of $0, indicating a grant rather than a purchase.
• The RSUs will fully vest on June 5, 2026, which is the first anniversary of the grant date.
• Following this transaction, Anne Beal beneficially owns 9,736 shares of Common Stock.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive sign of alignment between management and shareholder interests, and a standard practice for executive compensation, indicating stability and long-term commitment.

Positives

• The grant of 9,736 Restricted Stock Units (RSUs) to a director aligns the director's interests with long-term shareholder value.
• The RSUs vest over one year, indicating a commitment to retention and performance from a key board member.

Future Outlook

The grant of Restricted Stock Units (RSUs) to Director Anne Beal, with a full vesting date of June 5, 2026, indicates a future alignment of interests between the director and the company's long-term performance.

Industry Context

This Form 4 filing details an insider equity grant, a common practice in the healthcare technology sector to incentivize and retain key personnel, aligning their interests with long-term company performance.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a standard form of equity compensation in the technology and healthcare sectors, comparable to practices at companies like Teladoc Health (TDOC) or Livongo Health (acquired by Teladoc), which frequently use RSUs to incentivize executives and board members.
• The vesting schedule of one year is also a common practice for director grants, aiming to retain talent and align their interests with shareholder value over a defined period.

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Director Anne Beal constitutes a related party transaction, representing a form of equity compensation.

Stakeholder Impact

• Shareholders: Interests are potentially better aligned with the director due to equity ownership, fostering a long-term perspective on company performance.

Next Steps

• Monitoring the vesting of the 9,736 Restricted Stock Units (RSUs) on June 5, 2026.

Key Dates

Recommendation

Keywords

Omada Health, OMDA, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, equity grant, beneficial ownership